(Reuters) – Bank of New York Mellon Corp said on Thursday its employees will return to offices starting March 7, according to a memo seen by Reuters, in regions where conditions allow, subject to local requirements. (Reporting by Sohini Podder in Bengaluru; Editing by Krishna Chandra Eluri)
(Reuters) – American Express Co said on Thursday it would ask its New York employees to work from office at least once a week, starting March 1, according to a memo posted on the company’s website. (Reporting by Sohini Podder in Bengaluru; Editing by Anil D’Silva)
By Howard Schneider WASHINGTON (Reuters) – The U.S. Federal Reserve needs to begin raising interest rates but it is too soon to say how far or fast that process will need to go to bring inflation under control, Richmond Federal Reserve president Thomas Barkin said Thursday. He said it remained uncertain, given the ongoing pandemic …
Fed’s Barkin says rates should move to pre-pandemic levels, then assess next steps Read More »
MONTREAL (Reuters) – International Business Machines Corp is partnering with the Canadian province of Quebec to boost quantum computing in a collaboration that could help advance areas like battery development, a company official said on Thursday. IBM is deploying the quantum computer known as IBM Quantum System One in Canada for the first time, which …
IBM partners with Canadian province of Quebec in quantum computing push Read More »
By Saqib Iqbal Ahmed NEW YORK (Reuters) – A plunge in the shares of Facebook owner Meta Platforms Inc fueled a surge of options trading on Thursday, with some investors positioning for a quick rebound in the company’s stock. With Meta shares down around 25%, over 1.4 million options contracts on the company had changed …
Meta slide drives ‘insane’ options volume as some bet on bounce Read More »
By Michael Erman (Reuters) – Merck & Co said on Thursday it expects its 2022 sales to increase as much as 18 percent over last year, mostly on sales of its new COVID-19 pill, molnupiravir. The drugmaker said sales of the COVID-19 drug were $952 million in the fourth quarter, and it expects another $5 …
Merck sees 2022 sales up nearly 20%, mostly on molnupiravir Read More »
By Ann Saphir and Lindsay Dunsmuir (Reuters) – The Federal Reserve’s inflation fight should be its top priority, President Joe Biden’s nominees to the central bank’s Board of Governors told lawmakers on Thursday, signaling support for a hawkish pivot in U.S. monetary policy that’s already well underway. In a nearly three-hour Senate Banking committee confirmation …
By Manas Mishra (Reuters) -Biogen Inc on Thursday forecast 2022 profit well below Wall Street estimates as sales of its new Alzheimer’s disease drug stall, and said it was considering deals of all sizes. The U.S. Centers for Medicaid and Medicare Services (CMS) in January proposed https://www.reuters.com/business/healthcare-pharmaceuticals/future-biogens-aduhelm-hinges-us-medicare-alzheimers-coverage-2022-01-11/#:~:text=Jan%2011%20(Reuters)%20-%20The,treatment%20more%20than%20many%20expected to severely restrict coverage for Alzheimer’s drugs, including …
Biogen’s 2022 forecast well below Street view on Alzheimer’s drug uncertainty Read More »
By Noel Randewich (Reuters) – Retail investors appeared to be enthusiastically buying the dip in Wall Street’s biggest growth companies on Thursday as the U.S. stock market plunged following Facebook owner Meta Platforms Inc’s disappointing quarterly report. Investors on Fidelity’s online trading platform placed four buy orders for every sell order, with the social media …
As Meta plunge slams Wall Street, retail investors ‘buy the dip’ Read More »
By Diane Bartz WASHINGTON (Reuters) -The Senate Judiciary Committee on Thursday voted to approve a bill that would rein in app stores of companies they said exert too much market control, particularly Apple Inc and Alphabet Inc’s Google. The measure, sponsored by Democratic Senators Richard Blumenthal and Amy Klobuchar along with Republican Senator Marsha Blackburn, …
Bill targeting Apple and Google approved by U.S. Senate panel Read More »
